Tirzepatide is the first such drug that's made it to market
Retatrutide is a 39-amino-acid synthetic peptide that engages three metabolic receptors simultaneously: the GLP-1 receptor, the GIP receptor, and the glucagon receptor
The most common contributors to this imbalance are estrogen deficiency, particularly in postmenopausal women, and vitamin D deficiency
Becoming interested in product-related research at university, early on Knudsen set her sights on joining Novo a company specialised researching and developing industrial enzymes for different purposes
Nature 577 , 432436 (2020)
Fetching molecular profile Retatrutide Mechanism of Action Retatrutide is a synthetic peptide agonist of multiple hormone receptors including GLP-1, GIP, and glucagon receptors